Summary.-A modified electrophoretic mobility (EM) test was performed in 150 children to examine their lymphocyte sensitization to myelin basic protein (encephalitogenic factor). Measurements in the cytopherometer were facilitated by using devitalized sheep erythrocytes as indicator particles instead of macrophages. A significant decrease in EM was found in 29/30 children with acute lymphoblastic leukaemia and in 67/75 children with solid tumours, thus giving a false negative rate in malignant disease of 9/105 = 8.6%, as compared to 6 false positives among 45 children with non-malignant disorders; 5 of the latter " false/positive " 6 patients had autoimmune disease. Results of the EM test in the children with leukaemia were compared with those in 9 patients with non -Hodgkin's lymphoma and 2 with Hodgkin's disease at different stages, but no striking change was seen between different diseases, or after cessation of long-term immunosuppressive chemotherapy. Percentage of " slowing " ranged from 4 to 30o/. These results indicate that patients with lymphoid malignancies still have lymphocytes which had been sensitized by a common antigen of the malignant cell clone at the beginning of the disease. The EM test, furthermore, could serve as an additional diagnostic aid in differentiating benign from malignant masses in the abdomen, extremities or intracranial disease.
IN UTILIZING the macrophage electrophoretic mobility (MEM) test Field and Caspary (1970) found that the peripheral blood lymphocytes of patients with cancer were sensitized to a basic protein derived from human brain (encephalitogenic factor EF).
Subsequent reports confirmed the validitv of the MEM test in distinguishing between patients with benign and malignant diseases (Pritchard et al., 1972;  Goldstone, Kerr and Irvine, 1973; Irmscher et al., 1975; Shaw, Ettin and McPherson, 1976) .
The electrophoretic mobility (EM) test was recently modified by replacing guinea-pig macrophages by devitalized sheep erythrocytes as indicator particles ini the cytopherometer (Porzsolt, Tautz and Ax, 1975) . The modification made measurements in the cvtopherometer easier and more reliable.
The purpose of our investigation was (1) to apply this modified EM test with EF antigen to children with malignancies, as childhood tumours are clinically and cytologically different from adult cancer disease, and (2) particularly, to test lymphocytes of children with lymphoblastic leukaemia and lymphoma in longterm remission, where no EF sensitization has been previously reported.
MATERIALS AND METHODS
Patients.-Peripheral blood was obtained from 150 patients: 30 children Mwith acute lymphoblastic leukemia (ALL) in haematological remission, 75 children with solid tumours, and 45 children -with non-malignant diseases. Twenty-five of the patients (10 withALL + 15 with solid tumours) could be studied at the Children's Hospital, University of Munich, thanks to the generous help of Drs R. J. Haas and R. Eife. Treatment of the patients with ALL consisted of combination chemotherapy for 2 to 3 years, including prophylactic cranial irradiation, leading to a 5-year leukaemia-free survival of 30-50% (Pinkel, 1976 Dickinson, Caspary and Field (1973) .
Incubation procedures.-Incubations with antigen and indicator particles were performed according to Porzsolt et al. (1975) : 0-7 ml of the lymphocyte suspension was incubated with 3-0 ml of EF solution (0 3 mg EF/ml Hanks's balanced salt solution, HBSS) for 4 h at 37°C. The cells were then spun at 800 g for 15 min, and 3 ml of the supernatant was pipetted off for either immediate processing or storage at -20°C. After thawing, 3 ml of the supernatant was incubated with 1 ml of a suspension of tanned and sulphosalicylicacid-stabilized sheep erythrocytes (ETS, kindly supplied by Prof. Ax, Behringwerke, Marburg) (5 x 107 ETS/ml HBSS) for 90 min at 2300. As a control, supernatant without EF was prepared for each test, 1 ml ETS (5 x 107 ETS/ml HBSS) was incubated with 3 ml of a mixture of Dulbecco's medium and HBSS (7 : 30) for 90 min at 23°C in a water bath.
Cytopherometer.-Measurements of ETSelectrophoretic mobility were performed in a Zeiss cytopherometer, using a current of 6 mA at l10 V, and maintaining the observation chamber at a temperature of 230°C. All samples were presented for blind measurements in random order.
Measurements and calculations.-For each incubation mixture, 20 erythrocytes were timed with two stopwatches across the given distance of 16 ,um in the ocular eye-piece in both directions of the potential difference. To prevent timing errors by cell drifting, actual migration time was expressed by the formula t = 2a(b-a)/b (Porzsolt et al., 1975) in which t is the actual migration time, a the migration time in one direction, and b the total migration time in both directions. For each specimen, the mean actual migration time of 20 ETS indicator particles ± the standard deviation was determined in relation to the control which was freshly prepared for each day that measurements were made. Fig. 1 . The data of the 3 groups of Fig. 1 were statistically examined by the Scheffe test. The differences between the group of non-malignant disorders (with or without autoimmune disease) and the groups of malignant tumours and acute lymphoblastic leukaemia were highly significant (P < 0 001 
